The most recent data from the National Youth Tobacco Survey (NYTS) tell a story that you probably haven’t heard. Recently, the U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention released the 2022 NYTS results, which showed underage e-cigarette use had dropped below the level that led the FDA to declare an […]
Author Archives: Dr. Matthew Holman
Dr. Matthew Holman is Philip Morris International’s Vice President of U.S. Engagement & Regulatory Strategy. Prior to joining PMI in September 2022, Dr. Holman was most recently Office of Science director in the FDA’s Center for Tobacco Products. He wrote this for InsideSources.com.